Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,497.7
-3.1 (-0.12%)

 

  • STI Straits Times Index
    2,497.7
    -3.1 (-0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,506.6
    -6.4 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,455.4
    114.6 (0.47%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,338.1
    67.7 (2.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,360.3
    40.9 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,059.2
    20.8 (0.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,595.1M
  • Value: 1,877.8M
  • Rise: 152
  • Fall: 154
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.157-0.008
Oceanus^0.007-
Frasers L&C Tr1.420+0.010
NetLink NBN Tr0.965-0.010
Jiutian Chemical0.045-
Alset0.063+0.002
Rex Intl0.156+0.003
HPH Trust USD0.132+0.007
Golden Agri-Res0.141-0.001
Medtecs Intl1.070-0.110

World Indices

World Indices
Name Last Change
Nasdaq 10,793.3 -117.0
HSI 24,455.4 +114.6
HSCEI 9,803.1 +71.0
Jakarta 5,059.2 +20.8
Nikkei 225 23,360.3 +40.9
SSE Comp 3,338.1 +67.7
Shanghai A 3,498.5 +71.0
Shanghai B 251.8 +1.7
KOSPI 2,412.4 +6.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TFF PHARMACEUTICALS INC TFF PHARMACEUTICALS
Updated on 18 Sep 2020 (End of trading day)
Last (USD): 16.510 Change: +0.930 High: 16.510 Remarks: -
Change (%): +5.97 Low: 15.220
Open 15.220 Yesterday's Close 15.580000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 684,424 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.64565 Trailing EPS (USD) e -1.76832 NAV (USD) b 0.9802
PE a - Trailing PE f - Price / NAV b 16.8435
Dividend (USD) d - Cash In Hand (USD) g 0.9838 Issued & Paid-up Shares c 22,286,200
Dividend Yield (%) d - Price / Cash In Hand g 16.782 Treasury Shares h -
Market Cap (M) 367.945 Enterprise Value (M) 346.021
Piotroski F Score 3 Exchange Code TFFP Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 58.7
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Oct 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TFF PHARMACEUTICALS INC NASDAQ 367.945 - - 16.8435 -
Industry Pharmaceuticals: Major NASDAQ 1,764.977 114.250 47.925 2.7526 0.007
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 132,037.103 40.581 10.750 1.8571 2.229
Local Peer ROYALTY PHARMA PLC NASDAQ 25,486.310 10.852 10.852 6.1307 -
Local Peer CUREVAC NV NASDAQ 9,270.353 - - -193.4993 -
Local Peer REPLIGEN CORP NASDAQ 7,664.855 357.985 247.741 6.9679 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,870.418 - - 14.2359 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,224.628 6.038 6.863 0.7011 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,224.192 - - 10.5343 -
Local Peer ALLAKOS INC NASDAQ 4,114.620 - - 9.2049 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 3,734.899 - - 5.2543 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 3,608.413 - - 2.8724 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 3,546.312 - - 15.3104 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 3,329.816 - - 9.4748 -
Other Local Peers I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), TRICIDA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), BEYONDSPRING INC (NASDAQ), IMARA INC (NASDAQ), 89BIO INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), IMMUNIC INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), DURECT CORP (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), ESSA PHARMA INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), VERU INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), HARROW HEALTH INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), EVOLUS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), MEDIWOUND LTD (NASDAQ), EYENOVIA INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 10 ORD SHS (R/S) (NASDAQ), NOVAN INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), PAINREFORM LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), SUN BIOPHARMA INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ENTERA BIO LTD (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 392,764.088 25.978 25.865 6.2365 2.513
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 224,354.436 31.831 31.082 4.1692 2.026
Global Peer MERCK & CO INC NYSE 217,034.084 22.050 20.711 7.8516 2.644
Global Peer PFIZER INC NYSE 203,548.514 12.509 14.365 3.1638 3.969
Global Peer ABBVIE INC NYSE 159,028.831 20.279 23.041 10.8125 4.083
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 148,157.541 110.522 68.824 12.1072 2.427
Global Peer ELI LILLY AND COMPANY NYSE 147,458.980 31.794 26.247 36.0278 1.675
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 133,590.431 38.846 - 2.7211 2.802
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 125,864.166 21.555 20.521 13.9080 1.638
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 98,490.777 16.621 15.405 5.8641 4.968
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), HYGEIA HEALTH (HKEx), BAIYUNSHAN PH (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HENLIUS-B (HKEx), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), ADC THERAPEUTICS SA (NYSE), AKESO-B (HKEx), CMS (HKEx), HEPALINK (HKEx), TRAD CHI MED (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), INNOCARE-B (HKEx), OCUMENSION-B (HKEx), SSY GROUP (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), CKLIFE SCIENCES (HKEx), Kimia Farma Tbk. (IDX), CSTONE PHARMA-B (HKEx), Soho Global Health Tbk. (IDX), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), STARPHARMA HOLDINGS LIMITED (ASX), FUSEN PHARM (HKEx), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), PHARMA (Bursa), LANNETT CO INC (NYSE), ZHONGZHIPHARM (HKEx), DAWNRAYS PHARMA (HKEx), RECCE PHARMACEUTICALS LTD (ASX), CH BIOTECH SER (HKEx), BIOMX INC (NYSE American), KOTRA (Bursa), IX Biopharma (SGX), Merck Tbk. (IDX), NEW RAY MEDIC (HKEx), Hyphens Pharma (SGX), Phapros Tbk. (IDX), NEP INTERLONG (HKEx), ONCOSIL MEDICAL LIMITED (ASX), IP (SET), PAK FAH YEOW (HKEx), NOVA (Bursa), RACE ONCOLOGY LTD (ASX), BIOHLDG (Bursa), PALLA PHARMA LTD (ASX), CHARMACY PHAR (HKEx), NC HEALTHCARE (HKEx), NOXOPHARM LTD (ASX), WAI YUEN TONG (HKEx), IMMURON LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), INVION LTD (ASX), PURAPHARM (HKEx), ANNOVIS BIO INC (NYSE American), MEDLAB CLINICAL LIMITED (ASX), SANAI HEALTH GP (HKEx), AGEX THERAPEUTICS INC (NYSE American), JCT (SET), EXTRAWELL PHAR (HKEx), EXOPHARM LTD (ASX), PHARMAXIS (ASX), SUNZEN (Bursa), ACRUX (ASX), FIJI KAVA LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), SUDA PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), CELLMID LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+2.530
+18.10 %
10 Days -+3.850
+30.41 %
20 Days -+2.650
+19.12 %
Medium Term Return 3 Months -+10.830
+190.67 %
6 Months -+12.170
+280.41 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.440 - 16.260 Change From 1 Year Low +13.070 % Change From 1 Year Low (%) +379.94
Change From 1 Year High +0.250 % Change From 1 Year High (%) +1.54
2 Years Range 3.440 - 16.260 Change From 2 Years Low +13.070 % Change From 2 Years Low (%) +379.94
Change From 2 Years High +0.250 % Change From 2 Years High (%) +1.54
5 Years Range 3.440 - 16.260 Change From 5 Years Low +13.070 % Change From 5 Years Low (%) +379.94
Change From 5 Years High +0.250 % Change From 5 Years High (%) +1.54
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its thin film freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Toronto, Canada.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Sep 2020 15.220 16.510 15.220 16.510 684,424 -
17 Sep 2020 15.250 15.600 14.718 15.580 275,650 -
16 Sep 2020 14.790 15.470 14.450 15.270 243,798 -
15 Sep 2020 15.010 15.400 14.501 14.970 287,071 -
14 Sep 2020 14.090 15.030 13.890 14.540 240,850 -
11 Sep 2020 13.720 14.480 13.650 13.980 246,904 -
10 Sep 2020 13.110 14.390 13.110 13.660 402,858 -
09 Sep 2020 12.680 13.500 12.520 13.380 305,453 -
08 Sep 2020 12.040 13.250 11.410 12.920 282,325 -
04 Sep 2020 12.340 12.800 11.150 12.660 326,651 -
03 Sep 2020 13.500 13.950 12.050 12.660 589,919 -
02 Sep 2020 14.750 14.775 13.510 13.830 296,309 -
01 Sep 2020 14.910 15.250 14.060 14.950 287,159 -
31 Aug 2020 15.900 15.900 14.610 15.140 432,450 -
28 Aug 2020 15.235 16.260 14.600 16.020 451,094 -
27 Aug 2020 13.660 15.850 13.560 15.340 1,053,478 -
26 Aug 2020 12.760 13.865 12.510 13.570 569,440 -
25 Aug 2020 13.250 13.300 12.100 12.980 533,842 -
24 Aug 2020 14.000 14.390 12.900 13.470 813,052 -
21 Aug 2020 13.500 14.530 13.500 13.860 630,701 -
20 Aug 2020 13.730 13.950 13.100 13.690 548,528 -
19 Aug 2020 13.180 14.250 12.900 13.950 767,012 -
Summary
Current 2 Weeks
(04 Sep 2020 to 18 Sep 2020)
12.340 16.510 11.150 16.510 3,295,984 -
Previous 2 Weeks
(21 Aug 2020 to 03 Sep 2020)
13.500 16.510 11.150 12.660 5,657,444 -
4 Weeks from
(24 Jul 2020 to 20 Aug 2020)
7.000 16.510 6.740 13.690 19,093,999 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.